Christopher Anzalone

NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the life sciences, engineering, pharmaceutical, and education industries. Using Dip Pen Nanolithography® (DPN®), a patented and proprietary nanofabrication technology, scientists are enabled to rapidly and easily create micro-and nanoscale structures from a variety of materials on a range of substrates. This low cost, easy to use and scalable technique brings sophisticated nanofabrication to the laboratory desktop. Headquartered in the Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 250 patents and applications filed worldwide and licensing agreements with Northwestern University, Stanford University, University of Strathclyde, University of Liverpool, California Institute of Technology and the University of Illinois at Urbana-Champaign.

Calando Pharmaceuticals, Inc. engages in the design and development of drug-delivery-enhanced small molecule therapeutics. The company was established in 2000 and is headquartered in Pasadena, CA.

Nanotope, Inc. developed pharmaceutical products. The firm's products were used to regenerate specific tissues including neuronal, vascular, bone, myocardial, and cartilage. Its products targeted regeneration for prevention of paralysis associated with spinal cord injury and angiogenesis for advanced wound healing and the treatment of peripheral artery disease. The company was founded by Samuel I. Stupp and Christopher R. Anzalone and was headquartered in Skokie, IL.

Roche Madison, Inc. provides gene transfer technologies to the pharmaceutical industry. The company was founded in 1995 by Jon Wolff, James Hagstrom and Vladimir Budker and is headquartered in Madison, WI.

Unidym, Inc. manufactures, develops, and applies carbon nanotubes. It also provides bulk materials to customers and business partners. The company was founded in 2005 and is headquartered in Sunnyvale, CA.

Part of Arrowhead Pharmaceuticals, Inc., Benet Group LLC is a private equity firm. The company is based in Washington. The American company was founded by Christopher Richard Anzalone. Benet Group was acquired by Arrowhead Pharmaceuticals, Inc. on March 13, 2008.